The biosimilar era begins - PharmaTimes Magazine January 2016
2015 was the year biosimilars finally delivered on the hype. In February, Napp and Hospira launched Celltrion’s biosimilar infliximab, challenging MSD’s Remicade and potentially saving the NHS millions. - Magazine Article - PharmaTimes
by Dr SeungSuh 'Stanley' Hong
https://www.pharmatimes.com/magazine/2016/january_2016/the_biosimilar_era_begins